CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

Explore the PTAB proceeding IPR2023-00723 filed by Mylan Pharmaceuticals Inc. et al. on 2023-03-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00723

Filing Date

2023-03-16

Accorded Filing Date

2023-03-16

Institution Decision Date

2023-10-02

Last Modified Date

2023-12-22

Proceeding Type

IPR

Termination Date

2023-10-02

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 11908834
Respondent Patent Number 8129343
Legal Expiration Date
2030-12-06 Active (4.0 yrs remaining)
Patent Term Adjustment (PTA) +1722 Days Awarded
Injunction Viability (35 U.S.C. § 283) Active Threat
Respondent Inventor Jesper Lau et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Board Decisions & Rulings (1)

Institution Denied 2023-10-02
Denying Institution of Inter Partes Review 35 U.S.C. § 314
35 USC 312, 35 USC 314, 37 CFR 42.100

Address and Attorney/Agent Information

5 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVO NORDISK INC. - INTELLECTUAL PROPERTY DEPARTMENT
Customer Number 23650
Address 800 Scudders Mill Road, Plainsboro, NJ, 08536, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
56129 Wesley Nicolas +1 609-786-5418
62124 Leon Lum +1 609-786-4172
63996 Elizabeth Dingess-Hammond +1 317-433-3689
64519 Jianjie Hu +1 609-786-4129
74995 Kathryn Jones +1 804-426-7196

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇪🇺 Europe 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 1 U.S. Courts: 1
USPTO PTAB Trial 2023-03-16
IPR2023-00722

Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S

U.S. Continuation Sibling (8536122)
Status: Institution Denied
U.S. District Court 2023-01-27
1:23-cv-00013

Novo Nordisk, Inc. v. Viatris Inc.

Asserted Patent
Status: WVND
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

135
11

Notice: refund approved NOTICE

2023-12-22 FILING PARTY: BOARD
10

Petitioner's Request for Refund of Post-Institution Fees OTHER

2023-12-14 FILING PARTY: PETITIONER
3003

Exhibit 3003 Exhibit

2023-10-02 FILING PARTY: BOARD
9

Denying Institution of Inter Partes Review 35 U.S.C. § 314 DECISION

2023-10-02 FILING PARTY: BOARD
3002

Exhibit 3002 Exhibit

2023-10-02 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc